MDXHealth
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
18 sep 2007 - 08:29
Statutaire naam
MDXHealth
Titel
OncoMethylome Publishes Positive Clinical Trial Results for Urine-based Bladder Cancer Test
Bericht
Liege (Belgium) – September 18, 2007, 8:00am CET – OncoMethylome Sciences (Euronext Brussels: ONCOB, Euronext Amsterdam: ONCOA) published interim data from its ongoing bladder cancer clinical trial. The trial results showed that the urine test that OncoMethylome is developing can successfully detect bladder cancer, especially when the cancer is in early stages of its development and most difficult to detect. In addition, the test’s performance was drastically superior to that of cytology, which is currently the most widely used urine test for bladder cancer.
Gerelateerde downloads
Datum laatste update: 23 december 2025